Schnelle und zuverlässige Lieferung mit DHL. Alle Artikel auf Lager Innerhalb von 24 Std versandbereit. In 1-3 Werktagen bei Ihnen Ab 75€ versandkostenfrei!

Köp aktier i Xspray Pharma - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) announces today that its improved version of Sprycel® (dasatinib), HyNap-Dasa 505(b)(2), is expected to show a significantly improved product pro Company profile page for XSpray Pharma AB including stock price, company news, press releases, executives, board members, and contact information 2021-03-19 XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments. Xspray Pharma AB (publ) ('Xspray' or the 'Company') has, based on the authorisation granted by the annual general meeting on 14 May 2020, and in accordance with that the Company indicated in a press release on 20 October 2020, successfully carried out a directed share issue at a subscription price of SEK 142.50 per share (the 'Issue').. The subscription price has been determined through an The shareholders of Xspray Pharma AB (publ), Reg. No. 556649-3671, are summoned to the annual general meeting on Thursday 14 May 2020 at 11.00 CEST at Advokatfirman Vinge's office on Stureplan 8 in Stockholm.Registration starts at 10.30 CEST.

18:00 12/04/21. -21.49% - Issuer. Profile. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and Icelandic Stock Exchange First Page Nordic Indices European Indices US Indices Back. XSpray Pharma AB. QUOTES, GRAPH, TECHNICAL ANALYSIS XSPRAY PHARMA AB (PUBL) | 202 followers on LinkedIn.

Xspray Pharma publishes its annual report for 2020 . Press release 2021-03-18. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 . Press release 2021-03-05. Both groups in the two ongoing bioequivalence studies with Xspray Pharma’s product candidate HyNap-Dasa have been dosed

It employs technology platform in order to create a pipeline of anti-cancer products. The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments.

Mätare för teknisk analys visar realtidsvärderingar för de valda tidsramarna. Sammanfattningen för XSPRAY PHARMA AB baseras på de populäraste tekniska indikatorerna ‒ glidande medelvärden, oscillatorer och pivoter. Resultaten kan visas i en snabböversikt.

XSpray Pharma operates in Sweden. About the company XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a pipeline of anti-cancer Xspray Pharma AB (publ) is a pharma company with several product candidates in clinical development. Xspray Pharma uses its innovative, patented RightSize™ technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer. Xspray is a pharmaceutical company focused on developing improved and generic versions of already marketed drugs, mainly protein kinase inhibitors (PKIs) for targeted cancer treatment, and aims to Xspray Pharma AB is a product development company with multiple product candidates in clinical development.

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. News feed of Xspray Pharma AB. Bolaget grundades ursprungligen 2003 som Xspray Microparticles och har sitt huvudkontor i Solna. XSPRAY PHARMA AB (PUBL) | 215 följare på LinkedIn. www.xspraypharma.com | Xspray Pharma AB (publ) is a pharma company with several product XSpray Pharma AB (publ), 556649-3671 är ett aktiebolag i Solna som registrerades år 2003 och är verksamt inom Annan naturvetenskaplig och teknisk XSpray Pharma AB (publ),556649-3671 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status.
Snicken klintehamn

Press release 2021-03-18.

Årsredovisningen bifogas detta pressmeddelande och 30 jan 2018 Pressmeddelande Xspray Pharma föreslår en riktad nyemission om 1 350 000 aktier motsvarande cirka 88 MSEK för att expandera produktportföljen XSpray Pharma AB (publ) - Org.nummer: 5566493671.
Tre architecture

XSPRAY PHARMA AB (PUBL) | 201 followers on LinkedIn. www.xspraypharma.com | Xspray is a pharmaceutical company focused on developing improved and …

SvD Näringsliv - nyheter inom ekonomi och näringsliv, aktier och börs. Bevakning av internationella affärer och marknader. Motor- och IT-nyheter. Intervju med Xspray Pharma och VD Per Andersson på Penser Forskningsbolagsdag den 16 april 2020 2 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Å Ö. Nya inlägg; Inga nya inlägg; Du har postat i detta ämne; Ämnet är stängt; Ämnet har flyttats.

Vad gor en forvaltningsledare

Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) announces today that it has received positive preliminary results from a bioavailability study in healthy volunteers with an improved HyNap-Dasa version of the reference drug Sprycel™, demonstrating that absorption of HyNap-Dasa is not dependent on the gastric pH level.

Hos Nordnet kan du handle fra 0 kr.